This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Myeloproliferative diseases
MYELOPROF
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
944 |
4. Check minimum number of eventsNone |
944 |
5. Include endpoints |
3340 |
6. Filter based on genotype QC (FinnGen only) |
3252 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF12
Myeloproliferative diseases
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 3252 | 1705 | 1547 |
| Unadjusted period prevalence (%) | 0.65 | 0.60 | 0.71 |
| Median age at first event (years) | 63.65 | 62.05 | 65.41 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 3340
- Matched controls
- 33400
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
9950/3-C42.1
ICD-O-3
Polycythemia vera of bone marrow
+∞
307.7
413
*
9962/3-C42.1
ICD-O-3
Essential thrombocythemia of bone marrow
+∞
307.7
459
*
B99
ICPC
Blood/lymph/spleen disease other
65.9
307.7
181
29
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
+∞
307.7
335
*
L03AB05
ATC
interferon alfa-2b; parenteral
110.8
307.7
237
23
D45
ICD-10 Finland
Polycythaemia vera
1855.2
307.7
1267
11
D75.2
ICD-10 Finland
Essential thrombocytosis
4802.9
307.7
1050
*
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
71.3
307.7
269
41
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
38.8
307.7
383
111
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
5432.7
307.7
479
*
189
Kela drug reimbursment
Imatinib
151.5
307.7
186
13
L01XX05
ATC
hydroxycarbamide; oral
7251.3
307.7
1856
7
SPAT1074
SPAT
Venesection
164.4
307.7
313
21
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
111.8
307.7
2227
587
XW000
NOMESCO Finland
Bone marrow biopsy
26.7
307.7
1142
637
TPH00
NOMESCO Finland
Phlebotomy
296.4
307.7
438
17
D47.3
ICD-10 Finland
Essential (haemorrhagic) thrombocythaemia
+∞
307.7
1397
*
L01XX35
ATC
anagrelide; oral
+∞
269.5
255
*
9961/3-C42.1
ICD-O-3
Primary myelofibrosis of bone marrow
1113.1
216.0
209
*
M04AA01
ATC
allopurinol; systemic
3.6
210.0
890
3071
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
36.6
203.5
127
36
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.7
202.2
803
2649
D75.1
ICD-10 Finland
Secondary polycythaemia
19.8
164.8
128
67
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
24.9
157.2
111
46
9960/3-C42.1
ICD-O-3
Myeloproliferative neoplasm, NOS, of bone marrow
1620.7
156.5
151
*
212
Kela drug reimbursment
Gout
7.8
153.6
220
300
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
15.6
150.9
132
88
L01XE01
ATC
[U] imatinib
180.5
148.9
155
9
9863/3-C42.1
ICD-O-3
Chronic myeloid leukemia, NOS, of bone marrow
+∞
141.7
135
*
174
Kela drug reimbursment
Ruxolitinib
+∞
141.7
135
*
L03AB04
ATC
interferon alfa-2a; parenteral
179.8
132.5
138
8
374
Kela drug reimbursment
Ruxolitinib
+∞
129.0
123
*
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
28.6
120.5
81
29
L01EA01
ATC
imatinib; oral
316.3
120.1
121
*
L01EJ01
ATC
ruxolitinib; oral
+∞
117.4
112
*
R79.9
ICD-10 Finland
Abnormal finding of blood chemistry, unspecified
15.4
116.4
102
68
R79.8
ICD-10 Finland
Other specified abnormal findings of blood chemistry
14.1
112.8
104
76
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.2
112.6
497
1708
B74
ICPC
Malignant neoplasm blood other
39.6
108.0
66
17
D75.0
ICD-10 Finland
Familial erythrocytosis
61.1
107.6
60
10
B28
ICPC
Limited function/disability (B)
20.2
100.3
77
39
316
Kela drug reimbursment
Imatinib
260.4
99.3
101
*
TPH00, ,
SPAT
191.3
89.7
93
5
WW500
NOMESCO Finland
Blood transfusion
4.1
86.9
251
647
L03AA04, ,
ATC
28.5
83.2
56
20
L01XE18
ATC
[U] ruxolitinib
+∞
77.4
74
*
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
23.3
76.0
55
24
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
7.2
75.5
113
161
B03XA02
ATC
darbepoetin alfa; parenteral
5.1
72.3
157
322
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
12.4
66.8
66
54
B04
ICPC
Blood symptom/complaint
11.2
63.3
67
61
152
Kela drug reimbursment
Nilotinib
+∞
62.7
60
*
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
14.4
56.2
51
36
127
Kela drug reimbursment
Transplant complication
5.9
51.0
92
159
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
18.0
50.7
41
23
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
49.1
1687
12486
XX7BT
NOMESCO Finland
Radioactive phosphorus therapy
+∞
48.0
46
*
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
6.1
48.0
84
141
L01XX28
ATC
[U] imatinib
474.5
47.4
47
*
150
Kela drug reimbursment
Dasatinib
+∞
47.0
45
*
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
10.1
46.0
52
52
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
19.1
45.8
36
19
B03XA01
ATC
erythropoietin; parenteral
6.8
45.0
71
107
D72.9
ICD-10 Finland
Disorder of white blood cells, unspecified
14.4
40.8
37
26
L01XE08
ATC
[U] nilotinib
+∞
40.7
39
*
328
Kela drug reimbursment
Nilotinib
+∞
40.7
39
*
L01XE06
ATC
[U] dasatinib
+∞
40.7
39
*
D75.8
ICD-10 Finland
Other specified diseases of blood and blood-forming organs
54.1
40.5
48
9
R50.9
ICD-10 Finland
Fever, unspecified
1.9
39.4
536
2988
B01AB05
ATC
enoxaparin; parenteral
1.7
38.6
1125
7830
L01EA03
ATC
nilotinib; oral
+∞
37.6
36
*
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.4
37.2
262
1127
A05AA02
ATC
ursodeoxycholic acid; oral
4.9
37.0
81
167
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
34.9
1036
7206
L01AB01
ATC
busulfan; systemic
+∞
34.4
33
*
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
4.0
32.8
93
236
306
Kela drug reimbursment
Erythropoietin and darbepoetin
9.8
30.3
35
36
B01AC14
ATC
[U] anagrelide
+∞
30.2
29
*
2384A
ICD-9 Finland
Neoplasm of uncertain behaviour of other and unspecified sites and tissues, Polycythaemia vera
+∞
29.2
28
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.9
28.7
429
2449
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.1
27.9
286
1434
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.9
27.3
410
2342
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
46.1
26.5
32
7
C03CA01
ATC
furosemide; systemic
1.5
26.2
1130
8438
324
Kela drug reimbursment
Dasatinib
+∞
26.1
25
*
I81
ICD-10 Finland
Portal vein thrombosis
7.3
25.4
37
51
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.1
24.0
224
1082
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.5
23.6
156
651
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.9
23.5
343
1940
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
23.3
727
5034
D47.0
ICD-10 Finland
Histiocytic and mast cell tumours of uncertain and unknown behaviour
54.4
23.1
27
5
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
5.7
22.9
42
74
B75
ICPC
Neoplasm blood benign/unspecified
231.5
22.6
23
*
S97
ICPC
Chronic ulcer skin
2.1
22.6
238
1204
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
35.3
22.0
28
8
WW200
NOMESCO Finland
Immunization
3.0
21.9
100
345
9875/3-C42.1
ICD-O-3
Chronic myelogenous leukemia, BCR/ABL positive of bone marrow
+∞
21.9
21
*
D73.5
ICD-10 Finland
Infarction of spleen
25.2
21.7
30
12
L01EA02
ATC
dasatinib; oral
+∞
20.9
20
*
R04.0
ICD-10 Finland
Epistaxis
1.9
20.7
283
1566
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.5
20.5
786
5672
C92.9
ICD-10 Finland
Myeloid leukaemia, unspecified
105.7
19.6
21
*
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.8
19.5
332
1962
XW000, ,
SPAT
40.3
19.5
24
6
SPAT1088
SPAT
Blood transfusion
5.7
19.4
36
64
PH_2
NOMESCO Finland
Other procedures on veins
+∞
18.8
18
*
20899
ICD-8 Finland
Polycythaemia vera
+∞
18.8
18
*
170
Kela drug reimbursment
Bosutinib
+∞
18.8
18
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.1
18.7
180
880
C90.0
ICD-10 Finland
Multiple myeloma
3.7
18.3
58
160
L03AA02
ATC
filgrastim; parenteral
2.5
18.1
112
453
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.9
18.0
238
1302
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
52.8
17.9
21
*
L04AD01
ATC
ciclosporin; systemic
3.2
17.6
68
213
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
7.8
17.4
24
31
B01AA03
ATC
warfarin; systemic
1.5
17.3
687
4969
Z3231
NOMESCO Finland
Registered nurse
1.4
17.3
850
6405
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
2.5
16.9
103
414
2387X
ICD-9 Finland
Neoplasm of uncertain behaviour of other and unspecified sites and tissues, Other lymphatic and haematopoietic tissues[STATUS LYMPHO- ET MYELOPROLIFERATIVUS NUD]
+∞
16.7
16
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.0
16.2
187
976
D64.9
ICD-10 Finland
Anaemia, unspecified
1.6
16.1
371
2377
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.0
15.8
179
929
I50.9
ICD-10 Finland
Heart failure, unspecified
1.5
15.8
507
3507
D75
ICD-10 Finland
Other diseases of blood and blood-forming organs
160.7
15.5
16
*
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.5
15.4
37
83
D46.2
ICD-10 Finland
Refractory anaemia with excess of blasts [RAEB]
38.2
15.4
19
5
J01MA12
ATC
levofloxacin; systemic
1.5
15.1
589
4234
C95.9
ICD-10 Finland
Leukaemia, unspecified
45.2
15.1
18
*
D69.1
ICD-10 Finland
Qualitative platelet defects
21.1
14.6
21
10
360
Kela drug reimbursment
Bosutinib
+∞
14.6
14
*
121
Kela drug reimbursment
Severe hypofunction of sexual glands
2.8
14.5
70
250
K99
ICPC
Cardiovascular disease other
2.3
14.5
104
452
J01DB01
ATC
cefalexin; oral
1.4
14.4
2548
23301
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
2.4
14.3
98
417
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.6
14.2
397
2658
ZX120
NOMESCO Finland
Intravenous
1.7
14.2
297
1854
D47.7
ICD-10 Finland
Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue
22.3
14.2
20
9
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
14.5
14.0
23
16
H02AB06
ATC
prednisolone; systemic
1.3
13.9
1455
12287
TPH04
NOMESCO Finland
Cathetrisation of vein
1.4
13.9
666
4973
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.5
13.8
543
3904
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
53.6
13.8
16
*
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.3
13.4
102
455
NHQ40
NOMESCO Finland
Amputation of toe
2.9
13.0
60
210
B73
ICPC
Leukaemia
13.0
12.9
22
17
M10.9
ICD-10 Finland
Gout, unspecified
1.7
12.8
232
1393
UJF30
NOMESCO Finland
Ileoscopy through colon
1.6
12.6
306
1981
R16.1
ICD-10 Finland
Splenomegaly, not elsewhere classified
15.5
12.6
20
13
L01EA04
ATC
bosutinib; oral
+∞
12.5
12
*
2387B
ICD-9 Finland
Neoplasm of uncertain behaviour of other and unspecified sites and tissues, Other lymphatic and haematopoietic tissues[THROMBOCYTHAEMIA IDIOPATHICA]
+∞
12.5
12
*
D68.8
ICD-10 Finland
Other specified coagulation defects
3.6
12.4
40
112
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.5
12.4
477
3413
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
2.5
12.4
79
326
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.4
12.3
814
6394
Z2221
NOMESCO Finland
Medical doctor
1.4
12.3
780
6090
J02AC03
ATC
voriconazole; systemic
11.1
12.0
22
20
R72
ICD-10 Finland
Abnormality of white blood cells, not elsewhere classified
9.3
12.0
24
26
V03AC03
ATC
deferasirox; oral
46.8
11.9
14
*
T14.5
ICD-10 Finland
Injury of blood vessel(s) of unspecified body region
4.2
11.8
31
75
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.4
11.8
522
3832
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.6
11.8
246
1536
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.4
11.7
772
6055
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
2.6
11.7
67
263
ZYC05
NOMESCO Finland
Non-real-time text-based remote communication
3.0
11.6
49
163
D46.0
ICD-10 Finland
Refractory anaemia without ring sideroblasts, so stated
23.0
11.6
16
7
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.4
11.5
590
4439
PD4BC
NOMESCO Finland
Extensive arterigography of lower extremity with X-ray
2.8
11.5
58
213
C94.5
ICD-10 Finland
Acute myelofibrosis
+∞
11.5
11
*
XQ848
NOMESCO Finland
Dermatological photography
2.2
11.4
96
447
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
3.7
11.4
35
95
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.5
11.4
346
2358
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
4.0
11.0
31
79
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.0
11.0
124
645
A02BC02
ATC
pantoprazole; systemic
1.3
10.9
2112
19084
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
2.0
10.9
122
632
D47
ICD-10 Finland
Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue
43.5
10.9
13
*
C07AB07
ATC
bisoprolol; oral
1.3
10.8
1593
13903
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
2.2
10.8
84
379
L04AA01
ATC
[U] ciclosporin
2.9
10.8
48
165
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
1.7
10.7
177
1037
D73.1
ICD-10 Finland
Hypersplenism
17.9
10.7
16
9
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.4
10.6
578
4389
C03DA01
ATC
spironolactone; oral
1.5
10.6
384
2711
L57.0
ICD-10 Finland
Actinic keratosis
1.5
10.6
351
2436
K29
ICPC
Cardiovascular sympt/complt other
1.8
10.6
144
797
R58
ICD-10 Finland
Haemorrhage, not elsewhere classified
2.8
10.5
52
189
L01XE14
ATC
[U] bosutinib
+∞
10.4
10
*
2387A
ICD-9 Finland
Neoplasm of uncertain behaviour of other and unspecified sites and tissues, Other lymphatic and haematopoietic tissues[MYELOFIBROSIS]
+∞
10.4
10
*
2051A
ICD-9 Finland
Myeloid leukaemia, Chronic
+∞
10.4
10
*
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.5
10.4
361
2527
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
2.0
10.4
105
525
I26.0
ICD-10 Finland
Pulmonary embolism with mention of acute cor pulmonale
2.3
10.3
75
329
Y84
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.2
10.3
40
127
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
3.5
10.2
34
98
PD4AD
NOMESCO Finland
CT of lower extremity arteries
3.7
10.1
31
84
ZY010
NOMESCO Finland
Hospital outpatient
1.9
10.0
118
624
A46
ICD-10 Finland
Erysipelas
1.4
9.9
445
3268
J01FF01
ATC
clindamycin; systemic
1.3
9.8
768
6158
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.6
9.8
256
1687
ZYC01
NOMESCO Finland
Remote contact by phone
1.8
9.7
156
908
B01AB04
ATC
dalteparin; parenteral
1.8
9.6
155
902
PD4AC
NOMESCO Finland
Arterigography of lower extremity with X-ray
2.6
9.6
54
210
N02AX02
ATC
tramadol; systemic, rectal
1.3
9.6
1294
11119
UJF32
NOMESCO Finland
Coloscopy
1.3
9.4
794
6426
R71
ICD-10 Finland
Abnormality of red blood cells
7.5
9.4
21
28
B86
ICPC
OTHER HAEMATOLOGICAL ABNORMALITY
30.1
9.4
12
*
D69.9
ICD-10 Finland
Haemorrhagic condition, unspecified
4.7
9.3
21
45
WZC00
NOMESCO Finland
Treatment plan or consultation
1.3
9.3
1003
8384
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.7
9.1
357
4880
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
9.1
1171
9991
I82.88
ICD-10 Finland
Embolism and thrombosis of other specified veins
2.4
9.1
63
271
C93.1
ICD-10 Finland
Chronic myelomonocytic leukaemia
36.8
9.0
11
*
C92.7
ICD-10 Finland
Other myeloid leukaemia
36.8
9.0
11
*
R51.80
ICD-10 Finland
Headache
1.4
9.0
383
2785
B01AB10
ATC
tinzaparin; parenteral
1.5
8.9
288
1987
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.3
8.9
573
4462
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.4
8.8
411
3035
JN3AD
NOMESCO Finland
Abdominal CT examination
1.5
8.7
327
2322
H02AB09
ATC
hydrocortisone; systemic
2.2
8.7
69
315
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
1.6
8.7
198
1265
ZX112
NOMESCO Finland
Subcutaneous
2.2
8.6
69
316
B01AC04
ATC
clopidogrel; oral
1.4
8.6
521
4019
I82.0
ICD-10 Finland
Budd-Chiari syndrome
16.3
8.5
13
8
ZXD05
NOMESCO Finland
Urgent procedure
1.3
8.5
846
6981
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.5
8.5
267
1830
9989/3-C42.1
ICD-O-3
Myelodysplastic syndrome, NOS, of bone marrow
10.0
8.5
16
16
WX892
NOMESCO Finland
Monitored bed care
1.6
8.5
223
1471
ZXE00
NOMESCO Finland
One hour or less
1.3
8.5
1090
9278
9945/3-C42.1
ICD-O-3
Chronic myelomonocytic leukemia, NOS, of bone marrow
27.6
8.5
11
*
B99
ICD-10 Finland
Other and unspecified infectious diseases
2.3
8.4
62
274
C92.5
ICD-10 Finland
Acute myelomonocytic leukaemia
90.3
8.4
9
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.5
8.4
304
2146
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
1.8
8.3
128
736
373
Kela drug reimbursment
Ponatinib
+∞
8.3
8
*
WW304
NOMESCO Finland
Transfer of stem cells from registered domestic donator
+∞
8.3
8
*
O99.1
ICD-10 Finland
Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium
8.5
8.3
17
20
J01MA14
ATC
moxifloxacin; systemic
1.5
8.3
254
1734
S91.0
ICD-10 Finland
Open wound of ankle
3.0
8.1
35
119
B02BX05
ATC
eltrombopag; oral
10.0
8.0
15
15
TGC00
NOMESCO Finland
Bronchial lavation
2.1
8.0
76
373
AA1AD
NOMESCO Finland
CT of head and brain
1.3
8.0
839
6967
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.3
7.9
1031
8776
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.6
7.9
203
1334
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.5
7.7
278
1960
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
1.9
7.7
100
547
129
Kela drug reimbursment
Idiopathic thrombocytopaenia or granulocytopenia
6.4
7.7
19
30
R06.0
ICD-10 Finland
Dyspnoea
1.3
7.7
797
6602
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
1.9
7.7
86
448
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.4
7.6
282
1998
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
1.6
7.6
195
1281
JMA11
NOMESCO Finland
Laparoscopic total splenectomy
8.9
7.5
15
17
I67.6
ICD-10 Finland
Nonpyogenic thrombosis of intracranial venous system
7.1
7.5
17
24
PF1AT
NOMESCO Finland
Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)
2.8
7.4
35
125
M79.6
ICD-10 Finland
Pain in limb
1.2
7.3
1156
10033
1529, ,
Kela drug reimbursment
+∞
7.3
7
*
J01CA04
ATC
amoxicillin; systemic
1.2
7.3
2387
22319
A07AA02
ATC
nystatin; oral
1.6
7.2
169
1089
N02BE01
ATC
paracetamol; systemic, rectal
1.3
7.2
2781
26487
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
1.8
7.2
103
582
B59
ICPC
Blood and Immunity, Other therap proced/minor surg NEC
30.1
7.1
9
*
D58.2
ICD-10 Finland
Other haemoglobinopathies
20.1
7.1
10
5
I31.9
ICD-10 Finland
Disease of pericardium, unspecified
3.3
7.1
26
80
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.2
7.1
924
7848
N02AA05
ATC
oxycodone; systemic
1.3
7.1
543
4323
L71.9
ICD-10 Finland
Rosacea, unspecified
2.0
6.9
67
332
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
1.5
6.9
237
1657
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
2.2
6.8
52
235
J05AB11
ATC
valaciclovir; oral
1.4
6.7
372
2823
D06BB10
ATC
imiquimod; topical
1.6
6.7
140
876
TQW99
NOMESCO Finland
Other minor procedure on skin
1.6
6.6
151
966
K93
ICPC
Pulmonary embolism
2.6
6.6
35
133
A04AA01
ATC
ondansetron; systemic, rectal
1.5
6.6
214
1479
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
1.6
6.6
130
803
-69
ICPC
Other reason for encounter NEC
1.7
6.5
108
638
3AC01, ,
NOMESCO Finland
2.7
6.4
32
118
K49
ICPC
Cardiovascular, Other preventive procedure
70.0
6.4
7
*
R69
ICD-10 Finland
Unknown and unspecified causes of morbidity
2.1
6.4
55
261
S18
ICPC
Laceration/cut
1.2
6.4
1333
11854
L29.8
ICD-10 Finland
Other pruritus
2.5
6.3
38
154
X59
ICD-10 Finland
Exposure to unspecified factor
1.3
6.3
490
3903
I73.8
ICD-10 Finland
Other specified peripheral vascular diseases
8.2
6.3
13
16
I74.3
ICD-10 Finland
Embolism and thrombosis of arteries of lower extremities
2.6
6.3
35
137
NGQ20
NOMESCO Finland
Amputation of lower leg
3.3
6.3
23
71
L17
ICPC
Foot/toe symptom/complaint
1.2
6.3
786
6635
28999
ICD-8 Finland
Other disease of blood and blood-forming organs, Other and unspecified
+∞
6.3
6
*
175
Kela drug reimbursment
Deferasirox
+∞
6.3
6
*
I80.0
ICD-10 Finland
Phlebitis and thrombophlebitis of superficial vessels of lower extremities
1.7
6.2
101
593
WVA30
NOMESCO Finland
Intramuscular and subcutaneous injection
4.0
6.2
17
43
R60.0
ICD-10 Finland
Localized oedema
1.3
6.2
349
2660
N17.9
ICD-10 Finland
Acute renal failure, unspecified
1.6
6.1
121
748
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.2
6.1
949
8191
I50.0
ICD-10 Finland
Congestive heart failure
1.4
6.1
231
1648
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
1.6
6.1
148
964
L04AX02
ATC
thalidomide; oral
10.0
6.0
11
11
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.3
6.0
343
2616
L03.0
ICD-10 Finland
Cellulitis of finger and toe
1.5
6.0
205
1432
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
1.6
6.0
129
815
JCA22
NOMESCO Finland
Endoscopic ligature of oesophageal varices
5.2
6.0
17
33
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
1186
3944
4.11
309.54
2.7
2.6
22.56
22.30
%
0.23
1044
3346
2770
15929
5.33
307.65
21.6
8.6
5.20
4.17
e9/l
21.78
2586
13813
2691
13646
6.00
307.65
15.0
5.5
0.07
0.04
e9/l
74.62
2486
11701
1488
3404
7.08
307.65
4.1
2.4
1.87
1.79
%
2.36
1338
2984
1264
2544
7.38
307.65
3.9
2.5
77.96
68.95
e9/l
11.94
947
1947
2593
12421
5.86
307.65
16.5
5.8
1.04
0.66
%
86.19
2519
11515
897
417
29.04
307.65
1.3
1.2
29.00
44.52
u/l
0.91
743
365
2722
14108
6.02
307.65
16.5
5.7
0.22
0.19
e9/l
6.32
2533
12248
2689
13611
6.01
307.65
15.0
5.5
0.63
0.60
e9/l
1.64
2486
11672
2625
12847
5.87
307.65
17.8
6.1
8.32
8.80
%
9.50
2556
11944
2623
12786
5.90
307.65
16.7
5.7
2.75
2.85
%
1.90
2555
11870
2729
12781
7.21
307.65
18.7
6.0
—
—
—
0
0
893
2138
5.34
307.65
9.7
3.7
1.19
0.64
%
8.37
483
698
992
240
58.37
307.65
1.1
1.1
—
—
—
0
0
828
463
23.45
307.65
1.5
1.5
—
—
—
0
0
2188
3294
17.36
307.65
9.7
3.7
281.57
244.73
u/l
12.36
2131
3085
2602
12930
5.58
307.65
15.6
5.7
60.56
57.68
%
27.12
2526
12038
1927
7392
4.80
307.65
4.7
2.7
1478.14
5805.56
umol/l
8.66
1803
6372
2701
13957
5.89
307.65
15.4
5.6
1.97
1.91
e9/l
0.30
2544
12229
2635
13123
5.78
307.65
17.2
5.9
24.94
27.14
%
19.76
2566
12230
886
2240
5.02
307.65
9.9
3.9
0.27
0.11
%
3.16
466
710
1205
4190
3.93
292.71
2.6
2.5
2.41
2.29
g/l
10.26
1145
3861
1254
4513
3.85
289.05
2.7
2.5
13.27
12.62
umol/l
2.05
1198
4193
405
738
6.11
215.97
2.7
2.4
3.30
3.61
g/l
4.03
384
700
2428
14830
3.33
213.25
10.5
6.1
12.20
11.71
umol/l
0.95
2366
14041
308
478
7.00
191.90
8.6
3.2
1.65
1.43
%
0.52
272
418
1933
11144
2.74
174.08
3.9
2.8
157.86
141.45
ug/l
0.77
1804
10172
159
5
337.12
158.32
6.9
1.0
—
—
—
0
0
484
1385
3.92
147.17
1.8
1.7
1.11
1.54
g/l
20.85
415
1190
1952
12028
2.50
142.04
21.1
9.7
0.05
0.00
e9/l
4.23
1726
9802
86
22
40.10
141.26
1.0
1.0
—
—
—
0
0
196
302
6.83
122.18
8.9
3.1
64.45
55.55
%
5.49
158
250
319
770
4.47
121.27
2.3
2.1
93.25
89.69
%
1.92
283
750
1340
7366
2.37
120.27
2.6
2.2
4.74
3.02
mg/l
21.36
1158
6232
2804
21643
2.84
109.89
16.0
7.5
83.70
79.21
u/l
5.05
2734
20330
2128
14619
2.26
106.99
8.7
6.7
1.21
1.21
mmol/l
0.11
1806
12347
249
546
4.85
106.35
5.6
3.5
61.04
57.57
%
3.06
249
546
289
743
4.16
100.71
1.9
1.5
—
—
—
0
0
773
3796
2.35
85.16
6.0
5.7
1.04
1.03
mmol/l
0.31
731
3501
1909
13266
2.02
83.92
8.0
5.9
1.22
1.21
mmol/l
4.52
1763
12014
200
500
4.19
71.99
8.0
5.0
827.86
651.97
iu/ml
0.15
28
71
246
717
3.62
71.26
2.8
2.3
176.78
195.56
%
2.44
237
682
862
4725
2.11
70.69
4.7
3.1
0.82
0.81
mmol/l
1.28
822
4405
232
690
3.54
65.09
3.5
2.8
1.35
1.62
mg/l
6.48
223
620
1137
7070
1.92
64.16
1.8
1.6
20.34
20.50
nmol/l
0.12
1006
5955
98
145
6.93
63.22
7.1
3.1
—
—
—
0
0
619
3099
2.22
63.19
5.2
2.6
6.94
8.80
umol/l
2.04
564
2705
453
1983
2.49
62.99
2.7
2.8
10.07
10.57
g/l
1.42
415
1795
1705
12114
1.83
62.55
2.3
2.0
91.89
94.02
pmol/l
1.08
1050
6169
1756
12590
1.83
62.53
6.5
4.7
35.62
35.09
g/l
3.57
1657
11681
536
2558
2.30
61.25
2.7
2.6
66.62
66.33
g/l
0.38
490
2320
1130
7161
1.87
59.10
5.6
3.9
84.28
87.95
%
4.64
1073
6987
2161
16821
1.81
55.45
6.0
4.7
6.63
6.81
mmol/l
4.16
2083
15814
781
4499
1.96
53.77
2.8
2.0
31.77
29.95
s
10.12
739
4363
153
391
4.05
53.35
3.4
2.6
409.56
2276.93
u/ml
—
9
29
366
1563
2.51
53.26
1.8
1.9
1.51
1.47
g/l
0.09
332
1409
2458
20407
1.77
44.93
5.3
4.2
12.04
13.24
mm/h
3.27
2309
18775
53
57
9.43
44.52
1.5
1.3
—
—
—
0
0
925
5969
1.76
42.84
2.0
1.7
1.19
1.36
mg/l
1.02
726
4600
890
5850
1.71
37.79
1.8
1.8
1105.02
1175.02
nmol/l
1.50
689
4357
76
148
5.23
37.09
1.7
1.5
—
—
—
0
0
76
148
5.23
37.09
1.7
1.5
—
—
—
0
0
235
993
2.47
34.61
3.3
3.5
37.33
67.49
mg/l
1.31
205
802
235
993
2.47
34.61
3.3
3.4
53.65
117.18
mg/l
0.54
204
800
133
416
3.29
34.33
1.3
1.4
149.42
119.18
u/ml
0.39
24
83
230
966
2.48
34.31
3.3
3.4
1.64
1.68
ratio
0.03
22
76
263
1195
2.30
32.88
2.8
2.4
3.33
3.68
g/l
4.76
233
1081
263
1196
2.30
32.81
2.8
2.4
—
—
—
0
0
263
1197
2.30
32.74
2.8
2.4
6.92
7.44
g/l
5.86
234
1082
1756
13970
1.54
32.20
20.5
16.8
1.37
1.32
inr
1.48
574
3995
248
1118
2.32
31.55
2.7
2.4
10.92
10.33
g/l
1.02
218
996
247
1117
2.31
31.19
2.9
2.5
2.99
2.96
g/l
0.24
217
1003
135
452
3.07
31.12
1.2
1.2
—
—
—
0
0
134
463
2.97
29.24
2.5
1.5
—
—
—
0
0
134
463
2.97
29.24
2.5
1.5
—
—
—
0
0
226
1027
2.29
28.18
3.0
2.5
1.33
1.03
g/l
0.57
193
885
453
2674
1.80
27.13
6.1
7.1
9.73
10.38
mmol/l
1.26
427
2538
203
896
2.35
27.08
3.0
2.3
0.03
0.02
g/l
0.06
180
823
171
700
2.52
26.91
2.3
1.5
—
—
—
0
0
85
236
3.67
26.40
1.5
1.8
3.13
4.47
mg/l
3.96
80
230
729
4943
1.61
25.95
2.3
1.8
—
—
—
0
0
189
827
2.36
25.71
2.9
2.3
0.00
0.00
g/l
-0.00
169
770
191
840
2.35
25.68
2.9
2.3
0.00
0.00
g/l
-0.00
169
771
120
420
2.93
25.61
1.2
1.2
305.75
271.14
u/ml
0.53
79
254
164
678
2.49
25.27
2.5
1.5
—
—
—
0
0
206
944
2.26
25.16
2.8
2.2
38.63
37.63
g/l
1.55
177
829
1196
9105
1.49
24.91
3.3
3.1
2168.53
1541.25
ng/l
2.14
1049
7848
135
515
2.69
24.52
2.5
1.6
—
—
—
0
0
1136
8614
1.48
23.88
4.6
3.2
33.55
38.69
u/l
1.19
1089
8152
696
4780
1.58
23.14
1.5
1.5
2.33
2.54
g/l
1.79
449
2817
410
2466
1.76
22.83
3.3
3.8
1.22
1.23
mmol/l
2.10
356
2143
2933
27004
1.71
22.19
27.2
15.5
20.28
25.22
mg/l
15.52
2537
21725
366
2150
1.79
22.07
2.0
1.6
—
—
—
0
0
87
283
3.13
21.13
3.0
1.6
—
—
—
0
0
59
154
3.88
20.08
4.1
2.0
1187.94
543.58
e6/l
0.51
49
131
57
147
3.93
19.73
4.3
2.1
0.20
0.22
e9/l
0.29
50
131
88
306
2.93
19.07
3.0
1.5
—
—
—
0
0
56
148
3.83
18.75
3.6
1.6
—
—
—
0
0
56
148
3.83
18.75
3.6
1.6
—
—
—
0
0
37
71
5.26
18.43
1.3
1.1
72.24
86.85
%
1.67
21
40
2538
22920
1.45
17.78
36.5
18.2
16.52
15.16
%
27.61
2521
22468
111
456
2.48
17.40
1.3
1.2
—
—
—
0
0
47
116
4.10
17.29
4.1
1.7
—
—
—
0
0
47
116
4.10
17.29
4.1
1.7
—
—
—
0
0
36
72
5.04
17.13
1.3
1.4
77.90
84.57
%
0.38
21
42
47
118
4.03
16.91
4.0
1.7
—
—
—
0
0
49
127
3.90
16.88
1.7
2.4
82.41
96.72
%
1.88
44
121
2762
25432
1.50
16.81
5.1
4.1
1.33
1.30
mmol/l
0.99
2599
22874
75
258
2.95
16.61
3.1
1.5
—
—
—
0
0
75
258
2.95
16.61
3.1
1.5
—
—
—
0
0
75
258
2.95
16.61
3.1
1.5
—
—
—
0
0
53
147
3.65
16.59
2.0
2.7
35.17
41.51
%
1.14
23
88
230
1277
1.86
16.59
2.1
1.9
1.42
2.44
ug/l
0.99
206
1116
1119
8927
1.38
16.19
2.5
2.2
140.94
219.80
u/l
4.48
1051
8337
1544
13065
1.34
14.86
4.8
2.6
—
—
—
0
0
40
99
4.08
14.70
1.3
1.4
—
—
—
0
0
1218
9960
1.35
14.70
3.5
3.4
2.34
2.35
mmol/l
3.91
1073
8622
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
193
1058
1.87
14.49
3.8
2.9
0.36
0.35
u/ml
0.03
115
606
1087
8753
1.36
14.44
3.7
3.3
133.46
90.18
e6/l
0.23
856
6771
1103
8913
1.35
14.29
3.0
2.5
54.44
68.84
u/l
0.94
1016
8198
374
2470
1.58
14.23
2.1
2.2
397.90
370.78
nmol/l
1.54
347
2238
136
664
2.09
14.23
1.2
1.3
—
—
—
0
0
25
44
5.72
13.66
1.3
1.2
77.67
75.93
%
0.07
12
15
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
25
44
5.72
13.66
1.3
1.2
78.25
72.43
%
0.23
12
14
85
346
2.49
13.66
1.0
1.1
—
—
—
0
0
484
3431
1.48
13.21
2.0
1.8
—
—
—
0
0
484
3442
1.47
12.99
2.0
1.7
—
—
—
0
0
292
1857
1.63
12.98
1.7
1.7
—
—
—
0
0
42
119
3.56
12.80
1.6
2.4
1480.02
1207.54
u/ml
0.22
42
119
85
357
2.42
12.79
1.2
1.2
2.06
3.74
u/ml
0.84
32
114
78
317
2.50
12.60
1.7
1.4
—
—
—
0
0
78
317
2.50
12.60
1.7
1.4
—
—
—
0
0
994
8027
1.34
12.58
3.6
3.2
0.47
0.48
e6/l
0.02
779
6161
60
214
2.84
12.53
1.6
1.5
—
—
—
0
0
136
697
1.99
12.50
1.8
1.9
15.32
11.94
mg/l
1.10
119
639
1913
16917
1.31
12.50
3.7
3.2
60.44
52.99
u/l
2.67
1810
15531
83
349
2.41
12.47
1.2
1.2
4.72
5.51
u/ml
0.17
39
148
872
6920
1.35
12.36
5.1
2.3
—
—
—
0
0
293
1889
1.60
12.31
4.0
3.6
5.16
5.16
kpa
0.02
266
1789
23
22
10.52
12.23
1.3
1.5
—
—
—
0
0
135
696
1.98
12.21
1.1
1.1
110.91
90.40
titre
0.25
11
50
280
1794
1.61
12.07
3.9
3.6
1.82
1.91
mmol/l
0.14
200
1324
784
6142
1.36
12.03
2.9
2.6
4.87
5.29
e6/l
0.46
722
5519
2979
28246
1.51
11.92
28.6
18.2
139.46
139.65
mmol/l
3.63
2935
27516
399
2778
1.50
11.85
2.2
2.1
0.20
0.21
g/l
0.41
360
2579
50
168
3.01
11.63
1.9
2.0
—
—
—
0
0
103
491
2.13
11.53
1.6
1.4
—
—
—
0
0
70
283
2.51
11.47
1.2
1.2
51.48
60.20
u/l
0.87
64
258
2981
28315
1.49
11.34
30.3
18.3
4.01
3.98
mmol/l
5.89
2932
27541
179
1039
1.76
11.19
2.4
2.2
268.57
724.85
ug/l
1.52
170
977
25
53
4.75
11.17
1.6
1.3
—
—
—
0
0
1545
13411
1.28
11.07
5.2
5.2
0.00
0.00
estimate
0.50
406
2516
1326
11293
1.29
11.02
4.2
3.9
44.89
97.91
ng/l
0.74
1038
8253
69
284
2.46
10.90
2.8
2.8
—
—
—
0
0
715
5603
1.35
10.80
3.4
3.1
2.44
2.46
mmol/l
1.86
628
4916
267
1737
1.58
10.79
7.1
7.0
24.71
24.94
mmol/l
0.39
267
1727
77
336
2.32
10.70
1.0
1.1
111.08
116.22
%
0.70
71
306
1559
13585
1.28
10.69
3.9
3.9
0.00
0.00
estimate
1.08
403
2440
1545
13455
1.28
10.62
3.9
3.9
0.00
0.00
estimate
1.34
433
2703
1196
10088
1.29
10.61
4.3
3.8
111.85
116.00
e6/l
0.06
902
7243
176
1037
1.74
10.46
2.7
2.7
—
—
—
0
0
75
327
2.32
10.45
1.6
1.6
—
—
—
0
0
239
1530
1.61
10.34
2.9
3.2
4.40
4.41
pmol/l
0.11
197
1331
2791
26284
1.38
10.33
5.5
4.6
1.31
1.46
mmol/l
61.12
2639
23877
84
389
2.19
10.15
1.5
1.4
—
—
—
0
0
191
1161
1.68
10.14
2.0
1.8
—
—
—
0
0
133
730
1.86
10.03
1.5
1.5
0.22
0.24
g/l
1.17
120
691
2808
26506
1.37
9.93
5.6
4.6
4.18
4.59
mmol/l
82.93
2677
24247
2242
20521
1.28
9.91
4.3
4.0
15.12
14.93
pmol/l
2.75
2054
18420
1334
11480
1.27
9.86
2.5
2.2
78.42
78.59
nmol/l
0.08
1190
10117
156
904
1.76
9.84
1.5
1.2
—
—
—
0
0
29
77
3.79
9.76
6.8
2.1
—
—
—
0
0
83
390
2.16
9.69
6.8
6.7
11.24
12.02
mg/l
0.91
77
362
203
1270
1.64
9.65
2.9
1.9
—
—
—
0
0
60
246
2.47
9.60
1.3
1.2
—
—
—
0
0
135
755
1.82
9.60
1.4
1.5
1.13
1.18
g/l
1.44
124
713
85
405
2.13
9.58
1.6
1.5
—
—
—
0
0
22
31
7.13
9.49
1.3
1.8
—
—
—
0
0
2645
24804
1.32
9.32
5.4
4.8
2.04
2.09
mu/l
0.26
2476
22408
21
45
4.69
9.29
1.2
1.5
—
—
—
0
0
2719
25629
1.33
9.01
26.0
14.6
76.18
77.10
ml/min/173m2
1.47
2396
21225
41
146
2.83
8.69
1.1
1.1
—
—
—
0
0
118
659
1.82
8.47
1.6
1.5
—
—
—
0
0
412
3071
1.39
8.38
3.8
3.6
—
—
—
0
0
23
58
3.99
8.33
1.1
1.1
—
—
—
0
0
26
72
3.63
8.28
1.0
1.2
—
—
—
0
0
456
3475
1.36
8.08
7.5
7.0
4.99
5.10
kpa
1.70
436
3307
456
3475
1.36
8.08
7.5
7.0
11.90
12.05
kpa
0.19
434
3306
85
438
1.97
7.82
1.6
1.4
—
—
—
0
0
118
676
1.77
7.81
4.4
4.7
2.68
2.71
mmol/l
0.04
79
473
318
2294
1.43
7.80
3.2
2.7
56.90
63.12
ml/min/173m2
2.94
188
952
36
127
2.85
7.79
1.1
1.2
1.09
1.06
ratio
—
5
44
118
677
1.77
7.77
4.5
4.7
5.02
5.07
kpa
0.29
118
668
2843
27112
1.33
7.62
6.1
5.2
2.40
2.69
mmol/l
59.20
2699
24668
54
237
2.30
7.51
2.1
2.3
—
—
—
0
0
111
634
1.78
7.44
2.6
2.4
16.26
15.96
%
0.21
56
326
76
385
2.00
7.36
1.5
1.4
—
—
—
0
0
2669
25270
1.28
7.34
6.4
6.1
38.54
40.37
mmol/mol
22.34
2517
23142
2017
18520
1.22
7.33
5.1
4.8
2614.00
2187.37
e6/l
0.07
25
281
2979
28650
1.37
7.20
23.1
10.8
25.43
25.95
u/l
0.91
2922
27506
448
3465
1.34
7.17
7.6
7.0
1.09
1.17
mmol/l
0.13
353
2741
1177
10250
1.23
7.17
4.1
4.1
—
—
—
0
0
407
3105
1.35
7.14
7.9
7.3
95.11
95.48
%
0.48
393
2985
21
58
3.64
6.74
1.8
1.3
—
—
—
0
0
10
6
16.71
6.74
1.0
1.0
—
—
—
0
0
704
5828
1.26
6.71
4.1
3.9
579.05
588.49
ng/l
0.01
573
4767
174
1147
1.55
6.71
1.7
1.8
40.15
38.73
u/l
0.38
146
998
310
2290
1.39
6.64
3.5
3.8
87.55
93.60
ng/l
0.63
267
1950
860
7297
1.24
6.59
4.2
4.3
0.00
0.00
estimate
1.08
392
2395
351
2653
1.36
6.53
6.6
6.5
1.46
1.38
mmol/l
0.54
342
2589
173
1150
1.53
6.44
4.6
4.0
24.45
24.87
mmol/l
1.00
156
1061
10
7
14.32
6.39
1.8
1.0
—
—
—
0
0
34
132
2.59
6.20
1.1
1.1
—
—
—
0
0
342
2600
1.35
6.13
2.3
2.4
32.48
57.28
u/l
0.75
296
2231
367
2831
1.33
5.97
3.7
3.5
5.78
5.85
kpa
0.62
357
2745
41
178
2.32
5.92
1.5
1.6
9.06
6.67
u/l
0.22
35
149
365
2819
1.33
5.89
3.7
3.5
1.70
2.05
mmol/l
0.85
303
2367
221
1579
1.43
5.76
8.8
9.1
24.32
24.37
mmol/l
0.07
216
1531
17
35
4.88
5.73
1.1
1.4
8.88
272419.67
nmol/l
0.49
12
29
147
973
1.53
5.62
1.2
1.2
0.21
0.91
u/ml
—
8
86
43
197
2.20
5.50
1.1
1.2
125.00
114.05
titre
—
6
37
37
163
2.28
5.20
1.3
1.2
103.53
82.94
u/l
0.47
32
144
119
768
1.57
5.12
1.7
1.7
—
—
—
0
0
31
127
2.45
5.12
1.2
1.2
—
—
—
0
0
64
349
1.85
5.10
1.3
1.4
113387.50
92165.40
e6/l
0.14
38
206
41
191
2.16
5.06
1.8
1.3
—
—
—
0
0
556
4627
1.24
4.96
3.4
3.0
1.75
2.43
e6/l
1.51
293
2548
75
434
1.74
4.93
1.3
1.5
31.86
32.02
g/l
0.04
67
392
33
143
2.32
4.84
2.0
1.3
—
—
—
0
0
33
143
2.32
4.84
2.0
1.3
—
—
—
0
0
120
789
1.54
4.78
1.5
1.6
0.57
9.19
iu/ml
0.62
20
167
61
335
1.84
4.78
1.1
1.4
292.19
322.29
pmol/l
0.32
48
289
21
74
2.85
4.65
1.3
1.2
—
—
—
0
0
45
228
1.99
4.50
1.0
1.1
—
—
—
0
0
10
15
6.68
4.46
2.9
4.9
—
—
—
0
0
66
381
1.75
4.41
2.6
1.4
—
—
—
0
0
39
189
2.08
4.40
1.9
1.3
—
—
—
0
0
357
2864
1.28
4.36
8.7
7.7
118.49
121.22
g/l
1.39
347
2781
2745
26444
1.21
4.36
5.2
4.8
5.98
6.02
mmol/l
0.89
2512
23815
66
384
1.73
4.30
2.6
1.4
—
—
—
0
0
67
392
1.72
4.29
1.3
1.4
1913.15
1770.74
e6/l
0.12
46
285
28
122
2.31
4.10
1.5
5.7
—
60.29
—
0
28
334
2688
1.27
3.98
3.5
3.0
218.44
219.49
ng/l
0.02
309
2447
172
1264
1.38
3.90
4.6
5.1
1.92
1.60
%
1.56
159
1184
63
375
1.69
3.83
2.7
1.4
—
—
—
0
0
44
235
1.88
3.82
1.1
1.1
—
—
—
0
0
27
121
2.24
3.73
2.0
1.2
—
—
—
0
0
63
379
1.68
3.69
2.7
1.4
—
—
—
0
0
1592
14801
1.14
3.66
2.7
2.6
—
—
—
0
0
22
91
2.43
3.63
1.2
1.5
—
2024630.00
—
0
5
21
85
2.48
3.62
2.1
1.9
—
—
—
0
0
118
824
1.45
3.60
1.9
1.7
—
—
—
0
0
13
35
3.72
3.59
1.4
1.0
—
—
—
0
0
92
614
1.51
3.52
2.2
2.9
37.50
36.40
umol/l
0.11
82
544
8
13
6.17
3.50
1.0
1.5
—
—
—
0
0
32
158
2.04
3.50
1.3
1.2
20.70
16.80
u/l
0.45
27
137
12
32
3.76
3.38
1.4
1.0
—
—
—
0
0
69
436
1.59
3.37
1.1
1.1
—
—
—
0
0
573
4963
1.19
3.35
3.2
2.8
1.00
1.18
e6/l
0.63
311
2862
61
375
1.64
3.33
2.8
1.4
—
—
—
0
0
61
377
1.63
3.26
2.8
1.4
—
—
—
0
0
53
316
1.69
3.25
1.1
1.1
—
—
—
0
0
510
4387
1.19
3.23
1.3
1.3
26.08
36.99
iu/ml
1.54
160
1407
23
103
2.24
3.22
1.5
1.5
3.67
3.01
%
0.11
23
87
10
24
4.18
3.19
1.0
1.0
—
—
—
0
0
77
508
1.53
3.14
1.6
1.3
12.58
10.14
u/l
0.85
68
409
817
7315
1.15
3.13
1.6
1.6
1.49
1.36
mmol/l
2.03
702
6081
133
1791
0.73
3.13
1.9
1.8
—
—
—
0
0
286
2330
1.25
3.12
3.0
2.9
4.62
4.54
kpa
0.24
279
2251
75
493
1.53
3.11
1.8
1.9
5.15
4.87
mmol/24h
0.28
70
414
16
62
2.59
3.04
1.1
1.8
—
—
—
0
0
353
2950
1.22
3.04
2.3
2.2
193.12
156.05
ug/g
0.64
281
2323
221
1752
1.28
3.03
1.6
1.5
—
—
—
0
0
485
4185
1.19
2.96
1.2
1.2
9.61
12.91
u/ml
0.57
170
1572
51
310
1.66
2.94
3.6
3.7
—
—
—
0
0
62
397
1.57
2.91
1.3
1.2
0.18
0.38
nmol/l
—
5
25
51
312
1.64
2.88
1.3
1.3
272.51
277.46
mosm/kgh2o
0.83
43
233
34
185
1.85
2.87
1.1
1.1
—
—
—
0
0
34
185
1.85
2.87
1.1
1.1
—
—
—
0
0
163
1251
1.32
2.87
4.9
5.2
0.92
0.88
%
0.65
150
1173
45
267
1.69
2.85
1.2
1.1
—
—
—
0
0
29
150
1.94
2.84
1.0
1.0
—
—
—
0
0
109
787
1.40
2.83
1.6
1.7
—
—
—
0
0
82
562
1.47
2.82
1.0
1.2
—
7.94
—
0
7
94
664
1.43
2.77
1.2
1.2
1.76
3.65
u/ml
—
5
64
86
598
1.45
2.76
1.4
1.6
—
—
—
0
0
34
188
1.82
2.74
1.1
1.1
—
—
—
0
0
34
188
1.82
2.74
1.1
1.1
—
—
—
0
0
34
188
1.82
2.74
1.1
1.1
—
—
—
0
0
90
633
1.43
2.72
1.6
1.3
—
—
—
0
0
90
633
1.43
2.72
1.6
1.3
—
—
—
0
0
95
675
1.42
2.72
1.2
1.2
3.90
7.41
u/ml
—
8
118
33
182
1.82
2.69
1.1
1.1
—
—
—
0
0
87
611
1.44
2.66
1.4
1.3
—
—
—
0
0
79
546
1.46
2.63
1.2
1.2
1.26
7.82
u/ml
—
5
39
12
41
2.93
2.61
1.1
1.1
—
—
—
0
0
46
283
1.63
2.57
1.3
1.7
—
1093.33
—
0
9
28
149
1.89
2.55
1.3
1.4
1.29
1.21
nmol/l
0.16
19
118
234
1911
1.24
2.54
8.5
6.8
24.22
24.61
mmol/l
0.78
222
1813
201
1620
1.26
2.46
10.5
9.6
—
—
—
0
0
13
52
2.51
2.35
2.5
1.1
—
—
—
0
0
40
244
1.65
2.34
1.5
1.6
—
—
—
0
0
9
28
3.22
2.30
1.6
1.4
—
—
—
0
0
610
5465
1.14
2.29
1.3
1.2
2.02
1.44
u/ml
0.35
113
1383
27
148
1.83
2.28
2.6
3.8
—
—
—
0
0
19
92
2.07
2.27
2.2
2.0
1335.85
23277.38
e6/l
0.54
13
50
18
86
2.10
2.22
1.1
1.3
46.92
433.85
ug/l
0.65
11
42
9
29
3.11
2.22
2.4
4.3
—
—
—
0
0
83
602
1.39
2.18
1.2
1.1
—
—
—
0
0
7
19
3.69
2.15
1.6
1.1
—
—
—
0
0
91
672
1.36
2.15
2.2
2.1
131.33
127.61
g/l
0.45
70
488
106
802
1.33
2.14
1.2
1.2
—
—
—
0
0
172
1390
1.25
2.10
4.0
3.8
46.44
47.99
%
0.35
167
1374
20
102
1.97
2.10
2.1
1.8
42.89
48.84
ug/l
0.49
20
97
106
809
1.32
2.03
1.2
1.2
—
—
—
0
0
3013
29631
1.17
2.01
46.4
22.8
385.27
245.86
e9/l
309.59
2963
28799
184
1507
1.23
2.00
3.1
3.2
24.68
25.32
mmol/l
1.69
176
1459
3013
29638
1.17
1.97
46.4
22.8
8.91
6.79
e9/l
29.01
2953
28697
3011
29617
1.17
1.97
46.3
22.9
40.00
39.81
%
0.82
2843
27494
3013
29641
1.17
1.95
46.3
22.8
4.40
4.45
e12/l
2.31
2950
28702
26
149
1.75
1.94
1.2
1.1
—
—
—
0
0
3013
29647
1.17
1.91
46.6
22.9
131.39
134.37
g/l
17.08
2986
29152
54
373
1.46
1.89
1.4
1.4
—
—
—
0
0
110
855
1.30
1.87
1.4
1.4
281.81
274.57
ug/g
0.15
68
502
25
419
0.59
1.87
1.2
1.5
—
—
—
0
0
8
28
2.86
1.86
2.4
2.8
0.50
0.82
u/field
—
8
28
31
190
1.64
1.84
1.5
1.4
—
—
—
0
0
28
167
1.68
1.83
1.5
1.5
0.97
0.96
g/l
0.03
28
167
84
633
1.34
1.79
2.1
1.8
40.05
42.07
nmol/l
0.38
79
603
23
131
1.76
1.77
1.1
1.1
—
—
—
0
0
95
732
1.31
1.74
1.5
1.3
25.89
30.98
iu/l
1.02
85
620
20
110
1.82
1.72
1.9
2.8
66.82
111.62
umol/l
0.72
11
61
19
103
1.85
1.71
2.2
2.2
560.38
776.05
e6/l
0.43
13
76
27
164
1.65
1.68
1.6
1.5
—
—
—
0
0
18
97
1.86
1.66
1.6
1.4
16.57
22.41
%
0.53
18
89
23
134
1.72
1.66
1.3
1.7
—
—
—
0
0
27
165
1.64
1.64
1.6
1.5
—
—
—
0
0
28
173
1.62
1.63
3.2
1.6
—
—
—
0
0
25
151
1.66
1.59
2.1
2.5
—
—
—
0
0
34
224
1.52
1.54
5.6
4.9
50.29
39.22
u/ml
0.17
12
60
7
28
2.50
1.45
1.6
1.2
—
—
—
0
0
83
647
1.29
1.45
2.4
1.3
—
—
—
0
0
13
237
0.55
1.38
1.4
1.4
—
—
—
0
0
13
237
0.55
1.38
1.4
1.4
—
—
—
0
0
13
67
1.94
1.38
1.8
1.6
—
—
—
0
0
17
287
0.59
1.37
1.4
1.5
—
—
—
0
0
690
6409
1.10
1.37
1.6
1.7
20037947.01
25243148.64
pmol/l
0.09
534
5253
218
1893
1.16
1.34
2.9
2.1
12.85
12.73
nmol/l
0.08
195
1668
403
3646
1.12
1.34
5.0
4.7
31.63
33.07
%
2.11
318
2385
13
68
1.92
1.33
1.4
1.5
0.47
0.35
ug/l
—
8
36
37
259
1.43
1.29
1.2
1.5
—
—
—
0
0
11
55
2.00
1.27
1.1
1.1
—
—
—
0
0
8
35
2.29
1.26
1.0
1.1
—
—
—
0
0
8
35
2.29
1.26
1.5
1.5
—
—
—
0
0
27
178
1.52
1.26
1.2
1.7
—
—
—
0
0
306
2736
1.13
1.25
1.6
1.8
1.52
1.52
%
0.03
258
2356
15
254
0.59
1.25
1.3
1.5
—
—
—
0
0
392
3562
1.11
1.22
1.5
1.4
—
—
—
0
0
215
1882
1.15
1.21
2.7
3.0
126.45
127.99
g/l
0.39
205
1831
14
238
0.59
1.19
1.4
1.4
—
—
—
0
0
14
238
0.59
1.19
1.4
1.4
—
—
—
0
0
82
658
1.25
1.18
1.2
1.1
15.76
5.72
u/ml
—
9
64
44
324
1.36
1.17
8.2
6.7
7.52
7.59
mmol/l
0.05
37
275
170
1469
1.17
1.15
1.3
1.3
185.70
214.73
u/ml
0.26
159
1348
186
1620
1.16
1.13
1.3
1.3
53.20
55.53
au/ml
—
10
87
7
30
2.34
1.12
5.4
5.2
61.29
63.40
ug/min
—
7
25
204
1794
1.15
1.10
2.6
2.4
17.64
24.35
au/ml
0.37
18
112
5
21
2.38
1.09
1.4
1.0
—
—
—
0
0
28
193
1.45
1.09
1.4
1.2
—
—
—
0
0
176
1534
1.16
1.07
1.2
1.2
98.07
145.04
iu/ml
1.22
61
548
88
722
1.22
1.06
3.4
3.2
0.77
0.81
nmol/l
0.39
66
561
304
2755
1.11
1.02
2.3
2.4
5.23
7.17
ug/l
2.26
243
2401
33
238
1.39
1.02
2.4
2.2
690.42
626.92
ml
0.38
19
154
110
928
1.19
1.01
5.9
3.9
3.96
3.90
mmol/l
0.62
110
919
10
177
0.56
1.01
1.5
1.6
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
23
156
1.48
0.98
1.2
1.1
—
—
—
0
0
83
684
1.22
0.98
7.1
7.0
105.04
105.11
mmol/l
0.04
73
611
33
242
1.37
0.94
1.0
1.0
—
—
—
0
0
63
508
1.24
0.92
1.2
1.2
252.21
218.06
miu/ml
0.21
19
206
9
52
1.73
0.92
1.0
1.2
—
—
—
0
0
127
1097
1.16
0.91
2.4
3.2
399.85
4595.37
u/ml
0.94
109
927
535
5704
0.93
0.90
2.7
3.1
0.75
0.78
ug/l
0.23
361
3925
51
403
1.27
0.89
1.2
1.1
—
—
—
0
0
11
64
1.72
0.86
1.1
1.1
—
—
—
0
0
13
80
1.63
0.84
1.5
1.2
36.33
18.27
%
—
6
11
71
591
1.21
0.80
1.5
1.4
29.33
26.75
e6/l
0.05
58
450
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
71
592
1.20
0.79
1.6
1.4
886.26
1278.73
e6/l
0.19
61
478
25
182
1.38
0.77
1.0
1.1
33.75
42.26
mg/l
0.83
20
148
18
123
1.47
0.77
1.1
1.7
2.66
5.71
ug/l
0.67
11
98
15
222
0.67
0.77
1.0
1.0
888.80
694.67
ng/l
—
10
142
15
221
0.68
0.75
1.0
1.0
38.10
45.91
ng/l
—
10
141
15
220
0.68
0.74
1.0
1.0
277.30
320.19
ng/l
—
10
144
21
150
1.40
0.73
1.2
1.1
—
—
—
0
0
171
1536
1.12
0.73
3.2
2.8
0.26
0.30
e6/l
0.32
166
1500
51
416
1.23
0.72
1.5
1.9
32305.24
1982.60
u/l
1.00
13
166
5
26
1.92
0.70
1.2
1.1
—
—
—
0
0
33
256
1.29
0.70
1.2
1.3
—
—
—
0
0
7
41
1.71
0.70
1.4
1.2
—
—
—
0
0
12
77
1.56
0.68
1.3
1.1
—
—
—
0
0
11
69
1.60
0.68
1.0
1.2
—
—
—
0
0
83
715
1.16
0.67
1.3
1.2
—
—
—
0
0
7
43
1.63
0.66
1.4
1.2
—
—
—
0
0
12
78
1.54
0.65
1.3
1.1
—
—
—
0
0
10
62
1.61
0.65
1.0
1.2
—
—
—
0
0
5
29
1.73
0.64
1.0
1.0
—
—
—
0
0
131
1173
1.12
0.62
1.3
1.3
—
—
—
0
0
10
63
1.59
0.61
1.2
1.7
—
—
—
0
0
8
50
1.60
0.61
1.0
1.1
—
—
—
0
0
22
165
1.34
0.60
1.0
1.0
—
—
—
0
0
9
141
0.64
0.60
1.1
1.5
—
—
—
0
0
14
198
0.71
0.60
1.3
1.5
—
—
—
0
0
342
3214
1.07
0.58
3.0
4.0
13.52
22.11
ug/l
0.51
262
2633
6
35
1.72
0.57
1.3
1.0
—
—
—
0
0
6
36
1.67
0.56
1.0
1.2
2.65
1.86
umol/24h
—
6
36
8
55
1.46
0.56
1.1
1.1
—
6.00
—
0
8
8
122
0.65
0.54
1.6
1.3
—
—
—
0
0
6
38
1.58
0.54
1.5
1.2
29.84
35.17
nmol/l
—
6
29
37
304
1.22
0.53
1.2
1.1
2.97
2.09
u/ml
0.41
11
114
23
179
1.29
0.51
2.0
1.8
5.96
10.20
umol/l
0.55
16
115
6
41
1.46
0.50
1.5
1.4
—
—
—
0
0
23
180
1.28
0.49
1.3
1.3
9.25
9.67
mmol/l
0.20
23
173
30
243
1.24
0.49
1.1
1.4
25.26
28.90
u/l
0.27
22
197
14
189
0.74
0.48
1.0
1.6
109.79
84.80
umol/l
0.63
14
189
23
181
1.27
0.48
1.2
1.1
7.49
7.51
nmol/l
—
5
38
62
709
0.87
0.47
1.5
1.6
12097.20
14830.54
e6/l
0.33
45
499
12
85
1.41
0.46
1.3
1.1
—
—
—
0
0
5
84
0.59
0.45
3.0
2.3
154.80
150.59
nmol/l
—
5
73
768
7924
0.96
0.45
3.7
4.5
22.46
21.82
%
0.55
380
4003
21
165
1.27
0.45
1.6
1.2
—
—
—
0
0
22
174
1.27
0.44
1.8
1.3
2.96
1.32
u/ml
0.26
17
98
15
112
1.34
0.44
1.1
1.2
—
—
—
0
0
12
86
1.40
0.44
1.3
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
20
159
1.26
0.40
1.7
1.4
158.23
220.73
pmol/l
0.42
20
159
5
35
1.43
0.39
2.6
2.3
10.76
17.66
umol/l
—
5
35
5
35
1.43
0.39
1.2
1.1
—
—
—
0
0
14
106
1.32
0.39
1.1
1.3
113.10
162.09
mmol/24h
2.13
14
106
904
8816
1.03
0.38
3.2
3.2
1461.60
287.92
mg/l
3.58
569
5613
114
1235
0.92
0.36
1.0
1.0
—
—
—
0
0
65
723
0.90
0.35
1.9
1.8
—
—
—
0
0
24
287
0.84
0.34
1.1
1.0
0.91
4.57
u/ml
3.49
14
133
6
44
1.36
0.34
1.5
1.3
50.45
74.44
%
—
6
38
62
689
0.90
0.34
1.6
1.4
—
—
—
0
0
20
163
1.23
0.34
1.6
1.2
—
—
—
0
0
37
422
0.88
0.31
1.1
1.1
63.57
93.64
iu/ml
—
7
89
40
352
1.14
0.31
1.1
1.1
—
9.41
—
0
18
1009
9906
1.03
0.28
4.5
5.1
2.89
3.86
ug/l
0.60
892
8813
11
85
1.30
0.28
1.2
1.1
—
—
—
0
0
13
104
1.25
0.26
1.4
1.4
2.84
3.17
mmol/l
0.26
13
93
34
384
0.88
0.26
2.8
4.9
359.65
349.16
umol/l
0.15
26
331
356
3444
1.04
0.26
1.4
1.4
—
—
—
0
0
69
749
0.92
0.26
2.0
1.8
—
—
—
0
0
19
160
1.19
0.25
2.1
2.1
16.67
188.67
ug/min
—
6
36
9
74
1.22
0.25
1.0
1.4
10.76
9.06
ug/l
—
9
74
35
393
0.89
0.25
1.2
1.6
—
—
—
0
0
9
76
1.18
0.24
1.9
1.6
77.44
173.25
nmol/24h
—
9
76
364
3753
0.97
0.24
8.4
7.5
—
—
—
0
0
9
77
1.17
0.24
1.1
1.1
—
—
—
0
0
9
77
1.17
0.24
1.1
1.1
—
—
—
0
0
9
77
1.17
0.24
1.2
1.1
—
—
—
0
0
946
9303
1.02
0.24
3.7
3.8
13.33
9.00
mg/mmol
1.29
575
5840
16
134
1.19
0.22
1.9
1.2
192.06
138.01
nmol/l
1.41
16
134
68
631
1.08
0.22
4.1
3.7
27.46
29.42
mg/l
0.16
41
396
5
40
1.25
0.22
1.4
1.5
59.00
43.98
umol/l
—
5
40
10
79
1.27
0.22
1.5
1.2
89.90
109.68
%
—
10
68
578
5903
0.97
0.21
4.2
4.4
1.02
1.02
kg/l
1.00
88
898
0
12
0.00
0.21
0.0
1.2
—
2.42
—
0
12
29
258
1.13
0.21
1.2
1.5
21.27
29.00
%
0.67
15
158
0
13
0.00
0.21
0.0
1.2
—
7.81
—
0
13
29
324
0.89
0.20
1.1
1.1
0.19
1.65
u/ml
3.12
14
165
24
212
1.13
0.19
1.1
1.1
—
3.92
—
0
12
7
59
1.19
0.18
1.3
1.0
—
—
—
0
0
21
185
1.14
0.18
1.6
1.5
—
—
—
0
0
83
785
1.06
0.18
1.3
1.4
—
—
—
0
0
71
668
1.06
0.18
2.5
3.2
379.59
734.64
u/ml
0.31
61
613
921
9097
1.02
0.16
3.1
3.2
7.23
7.30
mmol/l
0.17
764
7565
8
71
1.13
0.16
1.0
1.0
—
—
—
0
0
42
390
1.08
0.15
1.9
2.2
16.00
23.80
mg/l
—
6
92
12
102
1.18
0.15
1.2
1.9
25.20
98.88
ug/l
0.46
12
90
9
81
1.11
0.15
1.0
1.1
—
—
—
0
0
19
169
1.12
0.14
1.5
1.2
—
—
—
0
0
10
84
1.19
0.14
3.9
2.4
—
—
—
0
0
10
84
1.19
0.14
3.9
2.4
—
—
—
0
0
76
728
1.04
0.12
2.6
2.2
241.85
100.13
ug/min
0.68
44
441
28
259
1.08
0.11
1.9
2.1
3.21
1.97
u/field
0.50
14
97
11
125
0.88
0.10
1.4
1.4
—
—
—
0
0
5
48
1.04
0.09
1.4
1.5
81.32
117.88
ng/l
—
5
48
37
350
1.06
0.09
1.3
1.5
68.80
60.82
%
0.61
21
215
13
144
0.90
0.08
1.1
1.0
—
—
—
0
0
10
113
0.88
0.08
9.2
13.1
970.60
790.57
nmol/l
—
10
108
9
86
1.05
0.07
1.0
1.1
1750.89
1684.65
miu/ml
—
9
86
9
87
1.03
0.07
1.1
1.1
—
—
—
0
0
24
253
0.95
0.05
1.0
1.0
2.29
1.14
u/ml
0.25
13
122
14
132
1.06
0.02
1.3
1.4
1.44
1.56
g/l
1.46
14
132
61
618
0.99
0.01
1.3
1.8
2.67
4.58
iu/l
2.17
18
198
25
243
1.03
0.01
1.6
1.5
0.26
0.29
nmol/l
0.14
19
184
12
126
0.95
0.00
1.2
1.3
20.01
24.82
umol/l
0.26
12
120
14
146
0.96
0.00
1.1
1.1
0.90
1.18
u/l
—
7
78
27
276
0.98
0.00
1.8
1.6
—
—
—
0
0
157
1564
1.00
0.00
1.7
1.9
—
—
—
0
0
10
105
0.95
0.00
1.1
1.0
—
—
—
0
0
20
195
1.03
0.00
1.3
1.4
1.21
1.21
promille
0.01
12
150
58
582
1.00
0.00
1.9
1.7
—
—
—
0
0
142
1416
1.00
0.00
1.7
1.8
—
—
—
0
0
57
567
1.01
0.00
1.3
1.7
0.81
0.83
nmol/l
0.07
48
464
59
587
1.01
0.00
1.3
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
1.82
—
0
7
0
8
0.00
-0.00
0.0
4.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
1478.67
—
0
6
0
8
0.00
-0.00
0.0
1.7
—
1.28
—
0
8
7
70
1.00
-0.00
1.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
6.8
—
67.00
—
0
6
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: MYELOPROF – Myeloproliferative diseases
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).